Logo image of IHS

IHS HOLDING LTD (IHS) Stock Fundamental Analysis

NYSE:IHS - New York Stock Exchange, Inc. - KYG4701H1092 - Common Stock - Currency: USD

5.41  -0.15 (-2.7%)

Fundamental Rating

4

Taking everything into account, IHS scores 4 out of 10 in our fundamental rating. IHS was compared to 33 industry peers in the Diversified Telecommunication Services industry. While IHS is still in line with the averages on profitability rating, there are concerns on its financial health. IHS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

IHS had negative earnings in the past year.
IHS had a positive operating cash flow in the past year.
IHS had negative earnings in each of the past 5 years.
IHS had a positive operating cash flow in each of the past 5 years.
IHS Yearly Net Income VS EBIT VS OCF VS FCFIHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B

1.2 Ratios

IHS has a Return On Assets of -38.16%. This is amonst the worse of the industry: IHS underperforms 90.91% of its industry peers.
IHS has a Return On Invested Capital of 13.30%. This is amongst the best in the industry. IHS outperforms 90.91% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IHS is above the industry average of 7.60%.
The 3 year average ROIC (9.60%) for IHS is below the current ROIC(13.30%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -38.16%
ROE N/A
ROIC 13.3%
ROA(3y)-27.43%
ROA(5y)-18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.6%
ROIC(5y)8.76%
IHS Yearly ROA, ROE, ROICIHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

The Operating Margin of IHS (35.25%) is better than 100.00% of its industry peers.
IHS's Operating Margin has improved in the last couple of years.
IHS has a Gross Margin of 48.82%. This is in the lower half of the industry: IHS underperforms 60.61% of its industry peers.
IHS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 35.25%
PM (TTM) N/A
GM 48.82%
OM growth 3Y3.33%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y6.43%
IHS Yearly Profit, Operating, Gross MarginsIHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -50

More info and screens

3

2. Health

2.1 Basic Checks

IHS has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
IHS has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IHS has more shares outstanding
IHS has a worse debt/assets ratio than last year.
IHS Yearly Shares OutstandingIHS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M
IHS Yearly Total Debt VS Total AssetsIHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

IHS has an Altman-Z score of -0.75. This is a bad value and indicates that IHS is not financially healthy and even has some risk of bankruptcy.
IHS has a worse Altman-Z score (-0.75) than 87.88% of its industry peers.
IHS has a debt to FCF ratio of 8.47. This is a slightly negative value and a sign of low solvency as IHS would need 8.47 years to pay back of all of its debts.
IHS has a Debt to FCF ratio (8.47) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.47
Altman-Z -0.75
ROIC/WACC1.59
WACC8.34%
IHS Yearly LT Debt VS Equity VS FCFIHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.33 indicates that IHS should not have too much problems paying its short term obligations.
The Current ratio of IHS (1.33) is better than 66.67% of its industry peers.
IHS has a Quick Ratio of 1.29. This is a normal value and indicates that IHS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.29, IHS is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.29
IHS Yearly Current Assets VS Current LiabilitesIHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 98.67% over the past year.
Looking at the last year, IHS shows a very negative growth in Revenue. The Revenue has decreased by -19.49% in the last year.
The Revenue has been growing slightly by 6.81% on average over the past years.
EPS 1Y (TTM)98.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.14%
Revenue 1Y (TTM)-19.49%
Revenue growth 3Y2.7%
Revenue growth 5Y6.81%
Sales Q2Q%5.23%

3.2 Future

The Earnings Per Share is expected to grow by 21.09% on average over the next years. This is a very strong growth
IHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.40% yearly.
EPS Next Y107.72%
EPS Next 2Y45.7%
EPS Next 3Y28.79%
EPS Next 5Y21.09%
Revenue Next Year0.47%
Revenue Next 2Y3.36%
Revenue Next 3Y4.52%
Revenue Next 5Y5.4%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
IHS Yearly Revenue VS EstimatesIHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
IHS Yearly EPS VS EstimatesIHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -2 -4

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IHS. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.98, the valuation of IHS can be described as reasonable.
87.88% of the companies in the same industry are more expensive than IHS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.43, IHS is valued rather cheaply.
Industry RankSector Rank
PE N/A
Fwd PE 8.98
IHS Price Earnings VS Forward Price EarningsIHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, IHS is valued cheaper than 90.91% of the companies in the same industry.
87.88% of the companies in the same industry are more expensive than IHS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.92
EV/EBITDA 5.36
IHS Per share dataIHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

IHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IHS's earnings are expected to grow with 28.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.7%
EPS Next 3Y28.79%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for IHS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IHS HOLDING LTD

NYSE:IHS (5/21/2025, 11:00:04 AM)

5.41

-0.15 (-2.7%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupTelecommunication Services
GICS IndustryDiversified Telecommunication Services
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-11 2025-08-11/bmo
Inst Owners22.1%
Inst Owner Change0%
Ins Owners6.05%
Ins Owner Change0%
Market Cap1.80B
Analysts80
Price Target7.78 (43.81%)
Short Float %0.15%
Short Ratio0.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)417.93%
Min EPS beat(2)-886.1%
Max EPS beat(2)1721.96%
EPS beat(4)1
Avg EPS beat(4)-7569.17%
Min EPS beat(4)-30725.1%
Max EPS beat(4)1721.96%
EPS beat(8)1
Avg EPS beat(8)-4876.52%
EPS beat(12)2
Avg EPS beat(12)-3671.92%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1.86%
Min Revenue beat(2)1.49%
Max Revenue beat(2)2.24%
Revenue beat(4)4
Avg Revenue beat(4)2.3%
Min Revenue beat(4)0.65%
Max Revenue beat(4)4.82%
Revenue beat(8)8
Avg Revenue beat(8)3.01%
Revenue beat(12)12
Avg Revenue beat(12)3.34%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.24%
PT rev (3m)1.67%
EPS NQ rev (1m)0%
EPS NQ rev (3m)476%
EPS NY rev (1m)-3.22%
EPS NY rev (3m)29.92%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)5.87%
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.98
P/S 1.05
P/FCF 3.92
P/OCF 2.47
P/B N/A
P/tB N/A
EV/EBITDA 5.36
EPS(TTM)-0.14
EYN/A
EPS(NY)0.6
Fwd EY11.14%
FCF(TTM)1.38
FCFY25.52%
OCF(TTM)2.19
OCFY40.43%
SpS5.13
BVpS-1.36
TBVpS-4.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.16%
ROE N/A
ROCE 16.84%
ROIC 13.3%
ROICexc 15.86%
ROICexgc 24.72%
OM 35.25%
PM (TTM) N/A
GM 48.82%
FCFM 26.9%
ROA(3y)-27.43%
ROA(5y)-18%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)9.6%
ROIC(5y)8.76%
ROICexc(3y)10.85%
ROICexc(5y)10.15%
ROICexgc(3y)17.62%
ROICexgc(5y)16.87%
ROCE(3y)12.16%
ROCE(5y)11.08%
ROICexcg growth 3Y10.15%
ROICexcg growth 5YN/A
ROICexc growth 3Y14.01%
ROICexc growth 5YN/A
OM growth 3Y3.33%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.27%
GM growth 5Y6.43%
F-Score5
Asset Turnover0.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 8.47
Debt/EBITDA 3.82
Cap/Depr 74.16%
Cap/Sales 15.72%
Interest Coverage 1.53
Cash Conversion 75.5%
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.29
Altman-Z -0.75
F-Score5
WACC8.34%
ROIC/WACC1.59
Cap/Depr(3y)110.28%
Cap/Depr(5y)98.41%
Cap/Sales(3y)24.14%
Cap/Sales(5y)22.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)98.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%102.14%
EPS Next Y107.72%
EPS Next 2Y45.7%
EPS Next 3Y28.79%
EPS Next 5Y21.09%
Revenue 1Y (TTM)-19.49%
Revenue growth 3Y2.7%
Revenue growth 5Y6.81%
Sales Q2Q%5.23%
Revenue Next Year0.47%
Revenue Next 2Y3.36%
Revenue Next 3Y4.52%
Revenue Next 5Y5.4%
EBIT growth 1Y-1.96%
EBIT growth 3Y6.12%
EBIT growth 5YN/A
EBIT Next Year145.8%
EBIT Next 3Y40.88%
EBIT Next 5Y27.02%
FCF growth 1Y80.73%
FCF growth 3Y9.8%
FCF growth 5Y3.71%
OCF growth 1Y-14.55%
OCF growth 3Y-0.94%
OCF growth 5Y2.59%